Lihua Tang Selected Research

Lihua Tang Research Topics

Disease

8	Neoplasms (Cancer) 10/2021 - 05/2016
7	Wounds and Injuries (Trauma) 05/2022 - 01/2012
3	Obesity 10/2023 - 09/2012
3	Narcolepsy 12/2021 - 07/2021
3	Cataplexy 12/2021 - 07/2021
3	Neoplasm Metastasis (Metastasis) 10/2020 - 04/2015
2	Infections 01/2023 - 01/2023
2	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 10/2020
2	Melanoma (Melanoma, Malignant) 04/2015 - 01/2013
2	Glucose Intolerance 09/2012 - 11/2010
2	Inflammation (Inflammations) 09/2012 - 11/2010
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2012 - 05/2011
1	Diabetes Mellitus 01/2024
1	Overweight 10/2023
1	Endotoxemia 10/2023
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 10/2023
1	Insulin Resistance 10/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 04/2023
1	Epilepsy (Aura) 04/2023
1	Stroke (Strokes) 04/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Pain (Aches) 11/2022
1	Rupture 11/2022
1	Threatened Abortion 11/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Cholangiocarcinoma 01/2021
1	Adenocarcinoma 01/2021
1	Rheumatoid Arthritis 01/2020
1	Experimental Arthritis 01/2020
1	Nasopharyngeal Carcinoma 12/2018
1	Colonic Neoplasms (Colon Cancer) 12/2018
1	Homozygous Familial Hypercholesterolemia 01/2018
1	Carcinogenesis 02/2017
1	Hepatocellular Carcinoma (Hepatoma) 02/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Liver Diseases (Liver Disease) 01/2017
1	Xanthomatosis (Xanthoma) 01/2017

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2009
6	SuspensionsIBA 05/2022 - 10/2020
4	CalciumIBA 12/2021 - 10/2020
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 11/2010
3	SodiumIBA 12/2021 - 07/2021
3	MagnesiumIBA 12/2021 - 07/2021
3	PotassiumIBA 12/2021 - 07/2021
3	Sodium Oxybate (gamma Hydroxybutyrate)FDA Link 12/2021 - 07/2021
2	Interleukin-6 (Interleukin 6)IBA 10/2023 - 01/2016
2	Messenger RNA (mRNA)IBA 01/2023 - 10/2021
2	antineoplaston A10 (A 10)IBA 03/2022 - 02/2021
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 12/2020 - 10/2020
2	Nifedipine (Adalat)FDA LinkGeneric 12/2020 - 10/2020
2	LDL CholesterolIBA 01/2018 - 01/2017
2	LDL Receptors (LDL Receptor)IBA 01/2018 - 01/2017
2	Immunoglobulin G (IgG)IBA 02/2013 - 09/2012
2	AntigensIBA 02/2013 - 11/2010
2	Coal (Coals)IBA 01/2012 - 05/2011
1	IonsIBA 01/2024
1	MetalsIBA 01/2024
1	phenolic acidIBA 01/2024
1	Polysaccharides (Glycans)IBA 10/2023
1	chaihu-longgu-muli decoctionIBA 04/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Glycoproteins (Glycoprotein)IBA 01/2023
1	VaccinesIBA 01/2023
1	Sialic AcidsIBA 01/2023
1	Virulence Factors (Pathogenicity Factors)IBA 01/2023
1	Progesterone FDA LinkGeneric 11/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2022
1	SolventsIBA 11/2022
1	Polysorbates (PSML)FDA Link 03/2022
1	Streptozocin (Streptozotocin)FDA Link 02/2022
1	Ursolic AcidIBA 02/2022
1	GSK2849330IBA 10/2021
1	Monoclonal AntibodiesIBA 10/2021
1	Complement System Proteins (Complement)IBA 10/2021
1	Neuregulin-1 (Neuregulin 1)IBA 10/2021
1	Competitive Endogenous RNAIBA 01/2021
1	Thrombopoietin (c-mpl Ligand)IBA 01/2021
1	B7-H1 AntigenIBA 10/2020
1	Calcium Channels (Calcium Channel)IBA 10/2020
1	MicroRNAs (MicroRNA)IBA 07/2020
1	HydrogelsIBA 01/2020
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2020
1	Methotrexate (Mexate)FDA LinkGeneric 01/2020
1	GelsIBA 01/2020
1	phytochlorinIBA 12/2018
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2018
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2018
1	Proprotein Convertase 9IBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	evolocumabIBA 01/2018
1	Neutralizing AntibodiesIBA 01/2018
1	tanshinoneIBA 02/2017
1	Ethanol (Ethyl Alcohol)IBA 01/2017

Therapy/Procedure

4	Therapeutics 10/2020 - 04/2015
3	Immunotherapy 10/2020 - 05/2016
1	Fecal Microbiota Transplantation 10/2023
1	Transjugular Intrahepatic Portasystemic Shunt 03/2022
1	Precision Medicine 01/2022
1	Intra-Articular Injections 01/2020
1	Photochemotherapy (Photodynamic Therapy) 12/2018